

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sister chromatid cohesion (GO:0007063) | 9.75044415 |
| 2 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 9.67802394 |
| 3 | eosinophil migration (GO:0072677) | 9.55229296 |
| 4 | regulation of mononuclear cell migration (GO:0071675) | 9.43073156 |
| 5 | branch elongation of an epithelium (GO:0060602) | 8.46679435 |
| 6 | positive regulation of chromosome segregation (GO:0051984) | 8.07990276 |
| 7 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 8.03334684 |
| 8 | fucose catabolic process (GO:0019317) | 7.85031963 |
| 9 | L-fucose metabolic process (GO:0042354) | 7.85031963 |
| 10 | L-fucose catabolic process (GO:0042355) | 7.85031963 |
| 11 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 7.78683409 |
| 12 | peptidyl-lysine dimethylation (GO:0018027) | 7.70689729 |
| 13 | vesicle fusion (GO:0006906) | 7.64778613 |
| 14 | ribosomal small subunit assembly (GO:0000028) | 7.41647264 |
| 15 | coenzyme A biosynthetic process (GO:0015937) | 7.23025704 |
| 16 | autophagic vacuole fusion (GO:0000046) | 6.88402839 |
| 17 | macrophage chemotaxis (GO:0048246) | 6.66710589 |
| 18 | organ growth (GO:0035265) | 6.62782584 |
| 19 | localization within membrane (GO:0051668) | 6.59447582 |
| 20 | axis elongation (GO:0003401) | 6.39465604 |
| 21 | regulation of beta-amyloid formation (GO:1902003) | 6.05538258 |
| 22 | establishment of mitotic spindle orientation (GO:0000132) | 5.98087220 |
| 23 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 5.95846241 |
| 24 | positive regulation of calcium ion import (GO:0090280) | 5.89112006 |
| 25 | negative regulation of GTPase activity (GO:0034260) | 5.87834265 |
| 26 | negative regulation of GTP catabolic process (GO:0033125) | 5.87834265 |
| 27 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.68292087 |
| 28 | monocyte chemotaxis (GO:0002548) | 5.53936453 |
| 29 | protein import into peroxisome matrix (GO:0016558) | 5.46636848 |
| 30 | organelle membrane fusion (GO:0090174) | 5.42477883 |
| 31 | double-strand break repair via nonhomologous end joining (GO:0006303) | 5.38251403 |
| 32 | non-recombinational repair (GO:0000726) | 5.38251403 |
| 33 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 5.33141599 |
| 34 | establishment of mitotic spindle localization (GO:0040001) | 5.29751914 |
| 35 | establishment of spindle orientation (GO:0051294) | 5.21926379 |
| 36 | seminiferous tubule development (GO:0072520) | 5.15038019 |
| 37 | acrosome assembly (GO:0001675) | 5.11150018 |
| 38 | negative regulation of circadian rhythm (GO:0042754) | 4.96605368 |
| 39 | histone H3-K9 methylation (GO:0051567) | 4.90487135 |
| 40 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.85411198 |
| 41 | positive chemotaxis (GO:0050918) | 4.68674801 |
| 42 | oxidative demethylation (GO:0070989) | 4.68533752 |
| 43 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.63425826 |
| 44 | organelle fusion (GO:0048284) | 4.62772660 |
| 45 | pantothenate metabolic process (GO:0015939) | 4.60918733 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.57849606 |
| 47 | regulation of stem cell maintenance (GO:2000036) | 4.57497071 |
| 48 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 4.54787566 |
| 49 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 4.54787566 |
| 50 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 4.54787566 |
| 51 | fucose metabolic process (GO:0006004) | 4.49070256 |
| 52 | regulation of autophagic vacuole assembly (GO:2000785) | 4.32706411 |
| 53 | protein targeting to lysosome (GO:0006622) | 4.29616584 |
| 54 | establishment of protein localization to vacuole (GO:0072666) | 4.29616584 |
| 55 | protein targeting to vacuole (GO:0006623) | 4.29616584 |
| 56 | coenzyme A metabolic process (GO:0015936) | 4.18919214 |
| 57 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.17165145 |
| 58 | fucosylation (GO:0036065) | 4.16301631 |
| 59 | histone H3-K9 modification (GO:0061647) | 4.11286835 |
| 60 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 4.07648301 |
| 61 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 4.05166802 |
| 62 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 4.03606705 |
| 63 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.03298499 |
| 64 | regulation of cellular amide metabolic process (GO:0034248) | 3.96124271 |
| 65 | single-organism membrane fusion (GO:0044801) | 3.91313033 |
| 66 | negative regulation of nucleotide catabolic process (GO:0030812) | 3.91277484 |
| 67 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.90247635 |
| 68 | membrane budding (GO:0006900) | 3.89016466 |
| 69 | establishment of spindle localization (GO:0051293) | 3.84421494 |
| 70 | negative regulation of nucleoside metabolic process (GO:0045978) | 3.72299135 |
| 71 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 3.70028665 |
| 72 | vesicle targeting (GO:0006903) | 3.65292786 |
| 73 | Golgi transport vesicle coating (GO:0048200) | 3.61959881 |
| 74 | COPI coating of Golgi vesicle (GO:0048205) | 3.61959881 |
| 75 | regulation of vacuole organization (GO:0044088) | 3.60485621 |
| 76 | establishment of protein localization to peroxisome (GO:0072663) | 3.55656297 |
| 77 | protein localization to peroxisome (GO:0072662) | 3.55656297 |
| 78 | protein targeting to peroxisome (GO:0006625) | 3.55656297 |
| 79 | DNA integration (GO:0015074) | 3.54124328 |
| 80 | regulation of calcium ion import (GO:0090279) | 3.53289055 |
| 81 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.49805157 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.48307468 |
| 83 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.48247546 |
| 84 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.47669530 |
| 85 | sodium-independent organic anion transport (GO:0043252) | 3.45483966 |
| 86 | negative regulation of macroautophagy (GO:0016242) | 3.40591366 |
| 87 | RNA methylation (GO:0001510) | 3.35999498 |
| 88 | peroxisomal transport (GO:0043574) | 3.32158460 |
| 89 | telomere maintenance via recombination (GO:0000722) | 3.30704092 |
| 90 | COPII vesicle coating (GO:0048208) | 3.28372216 |
| 91 | labyrinthine layer development (GO:0060711) | 3.28044922 |
| 92 | peptidyl-lysine trimethylation (GO:0018023) | 3.27176645 |
| 93 | prenylation (GO:0097354) | 12.7531037 |
| 94 | protein prenylation (GO:0018342) | 12.7531037 |
| 95 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 12.4085003 |
| 96 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 12.4085003 |
| 97 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 12.4085003 |
| 98 | negative regulation of Ras GTPase activity (GO:0034261) | 12.3112470 |
| 99 | eosinophil chemotaxis (GO:0048245) | 10.5568744 |
| 100 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 10.3125489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 9.11007984 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 6.36146672 |
| 3 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 4.59826226 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.45029670 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.48948812 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.97681235 |
| 7 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.73346913 |
| 8 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.64233916 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.60522780 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.36710910 |
| 11 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.36212528 |
| 12 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.35850102 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.35329766 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 11.7532144 |
| 15 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.93446862 |
| 16 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.93446862 |
| 17 | RXR_22108803_ChIP-Seq_LS180_Human | 1.84220928 |
| 18 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.75041897 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65000178 |
| 20 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60255086 |
| 21 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60255086 |
| 22 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60255086 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57513814 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57315683 |
| 25 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.50836767 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42899875 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40699647 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.38478345 |
| 29 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36583542 |
| 30 | GATA3_26560356_Chip-Seq_TH1_Human | 1.34613952 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29547314 |
| 32 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.24015983 |
| 33 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22329884 |
| 34 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21303804 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18971676 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.18946344 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.18130033 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10487248 |
| 39 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.08984630 |
| 40 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07294954 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04463588 |
| 42 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.03868892 |
| 43 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00313368 |
| 44 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96955595 |
| 45 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96899713 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95037609 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.89184299 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88825928 |
| 49 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88351412 |
| 50 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.86961295 |
| 51 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.86790748 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86755866 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86458171 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85996990 |
| 55 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82183888 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81602292 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79643567 |
| 58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79342776 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.78921845 |
| 60 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78427700 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.76664227 |
| 62 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.76271757 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.75273212 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.72146752 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71686173 |
| 66 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.66610205 |
| 67 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.66481026 |
| 68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.66251471 |
| 69 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.63292492 |
| 70 | FUS_26573619_Chip-Seq_HEK293_Human | 0.62538176 |
| 71 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.62471708 |
| 72 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.62018532 |
| 73 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.61059295 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.59637110 |
| 75 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.59403065 |
| 76 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.59305698 |
| 77 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.58684663 |
| 78 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.57524721 |
| 79 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.57504110 |
| 80 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.57317711 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.57282723 |
| 82 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.57258590 |
| 83 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.56982294 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.56962732 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.56741828 |
| 86 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56114754 |
| 87 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.54612105 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.53399188 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52774356 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.52662400 |
| 91 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.52250761 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.51952336 |
| 93 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.51628102 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.51503537 |
| 95 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.51235424 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.50851979 |
| 97 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.50809646 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.50796988 |
| 99 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.50713395 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.50523106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 5.47907265 |
| 2 | MP0000467_abnormal_esophagus_morphology | 3.35971081 |
| 3 | MP0001664_abnormal_digestion | 3.22270337 |
| 4 | MP0001663_abnormal_digestive_system | 3.11676923 |
| 5 | MP0001919_abnormal_reproductive_system | 2.64534187 |
| 6 | MP0003115_abnormal_respiratory_system | 2.60565483 |
| 7 | MP0002751_abnormal_autonomic_nervous | 2.53464407 |
| 8 | MP0000383_abnormal_hair_follicle | 2.49832489 |
| 9 | MP0005381_digestive/alimentary_phenotyp | 2.41335211 |
| 10 | MP0000566_synostosis | 13.0653008 |
| 11 | MP0003303_peritoneal_inflammation | 10.1034596 |
| 12 | MP0005166_decreased_susceptibility_to | 1.78133851 |
| 13 | MP0001915_intracranial_hemorrhage | 1.74099876 |
| 14 | MP0010678_abnormal_skin_adnexa | 1.72584182 |
| 15 | MP0002876_abnormal_thyroid_physiology | 1.72271584 |
| 16 | MP0003453_abnormal_keratinocyte_physiol | 1.60893259 |
| 17 | MP0000534_abnormal_ureter_morphology | 1.59625159 |
| 18 | MP0003937_abnormal_limbs/digits/tail_de | 1.57919876 |
| 19 | MP0005389_reproductive_system_phenotype | 1.53129030 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 1.52818852 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.52818852 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.51260314 |
| 23 | MP0000428_abnormal_craniofacial_morphol | 1.40560998 |
| 24 | MP0005501_abnormal_skin_physiology | 1.19507906 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.10392864 |
| 26 | MP0000858_altered_metastatic_potential | 1.08605234 |
| 27 | MP0000490_abnormal_crypts_of | 1.08539067 |
| 28 | MP0001286_abnormal_eye_development | 1.06899696 |
| 29 | MP0001293_anophthalmia | 1.02478474 |
| 30 | MP0003329_amyloid_beta_deposits | 0.97593628 |
| 31 | MP0002019_abnormal_tumor_incidence | 0.89737996 |
| 32 | MP0002109_abnormal_limb_morphology | 0.86641247 |
| 33 | MP0000470_abnormal_stomach_morphology | 0.84003403 |
| 34 | MP0001963_abnormal_hearing_physiology | 0.81482716 |
| 35 | MP0002115_abnormal_skeleton_extremities | 0.81378260 |
| 36 | MP0001764_abnormal_homeostasis | 0.81063490 |
| 37 | MP0000026_abnormal_inner_ear | 0.78253307 |
| 38 | MP0003942_abnormal_urinary_system | 0.76535950 |
| 39 | MP0000358_abnormal_cell_content/ | 0.75035188 |
| 40 | MP0001986_abnormal_taste_sensitivity | 0.72531498 |
| 41 | MP0010155_abnormal_intestine_physiology | 0.71726547 |
| 42 | MP0005197_abnormal_uvea_morphology | 0.66606492 |
| 43 | MP0000477_abnormal_intestine_morphology | 0.65057951 |
| 44 | MP0009763_increased_sensitivity_to | 0.64279614 |
| 45 | MP0005423_abnormal_somatic_nervous | 0.63989998 |
| 46 | MP0002405_respiratory_system_inflammati | 0.63030162 |
| 47 | MP0000604_amyloidosis | 0.62642192 |
| 48 | MP0005508_abnormal_skeleton_morphology | 0.62455215 |
| 49 | MP0000432_abnormal_head_morphology | 0.60870082 |
| 50 | MP0009672_abnormal_birth_weight | 0.59821587 |
| 51 | MP0002210_abnormal_sex_determination | 0.56863675 |
| 52 | MP0005023_abnormal_wound_healing | 0.56254853 |
| 53 | MP0002184_abnormal_innervation | 0.53604042 |
| 54 | MP0001175_abnormal_lung_morphology | 0.53344449 |
| 55 | MP0000681_abnormal_thyroid_gland | 0.52903426 |
| 56 | MP0003935_abnormal_craniofacial_develop | 0.51427683 |
| 57 | MP0000377_abnormal_hair_follicle | 0.47404977 |
| 58 | MP0002113_abnormal_skeleton_development | 0.46975789 |
| 59 | MP0005253_abnormal_eye_physiology | 0.45745194 |
| 60 | MP0008058_abnormal_DNA_repair | 0.43607250 |
| 61 | MP0003448_altered_tumor_morphology | 0.42969843 |
| 62 | MP0005410_abnormal_fertilization | 0.40172667 |
| 63 | MP0003878_abnormal_ear_physiology | 0.38523586 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 0.38523586 |
| 65 | MP0003638_abnormal_response/metabolism_ | 0.37344555 |
| 66 | MP0000627_abnormal_mammary_gland | 0.37325223 |
| 67 | MP0003136_yellow_coat_color | 0.37246269 |
| 68 | MP0005391_vision/eye_phenotype | 0.35851756 |
| 69 | MP0002735_abnormal_chemical_nociception | 0.35405556 |
| 70 | MP0000163_abnormal_cartilage_morphology | 0.33552979 |
| 71 | MP0003936_abnormal_reproductive_system | 0.33400925 |
| 72 | MP0002136_abnormal_kidney_physiology | 0.32957668 |
| 73 | MP0005025_abnormal_response_to | 0.32698177 |
| 74 | MP0002697_abnormal_eye_size | 0.32103863 |
| 75 | MP0000350_abnormal_cell_proliferation | 0.30595567 |
| 76 | MP0002822_catalepsy | 0.29036394 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.28260008 |
| 78 | MP0010771_integument_phenotype | 0.27510405 |
| 79 | MP0008004_abnormal_stomach_pH | 0.27301648 |
| 80 | MP0002168_other_aberrant_phenotype | 0.27244601 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 0.24678674 |
| 82 | MP0002452_abnormal_antigen_presenting | 0.24479642 |
| 83 | MP0005390_skeleton_phenotype | 0.23355541 |
| 84 | MP0002161_abnormal_fertility/fecundity | 0.21982878 |
| 85 | MP0004019_abnormal_vitamin_homeostasis | 0.19038188 |
| 86 | MP0001929_abnormal_gametogenesis | 0.18728140 |
| 87 | MP0009931_abnormal_skin_appearance | 0.18530698 |
| 88 | MP0003077_abnormal_cell_cycle | 0.17582615 |
| 89 | MP0003880_abnormal_central_pattern | 0.17557671 |
| 90 | MP0002736_abnormal_nociception_after | 0.17499722 |
| 91 | MP0002092_abnormal_eye_morphology | 0.17441685 |
| 92 | MP0005332_abnormal_amino_acid | 0.17197147 |
| 93 | MP0003091_abnormal_cell_migration | 0.16985975 |
| 94 | MP0002116_abnormal_craniofacial_bone | 0.16133236 |
| 95 | MP0002081_perinatal_lethality | 0.16082859 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.15967885 |
| 97 | MP0000955_abnormal_spinal_cord | 0.15787555 |
| 98 | MP0003195_calcinosis | 0.15657678 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.15354133 |
| 100 | MP0000049_abnormal_middle_ear | 0.13309613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Duplicated collecting system (HP:0000081) | 9.28607113 |
| 2 | Long foot (HP:0001833) | 9.10633931 |
| 3 | Abnormality of the renal collecting system (HP:0004742) | 8.30122593 |
| 4 | Acute lymphatic leukemia (HP:0006721) | 7.22117620 |
| 5 | Large for gestational age (HP:0001520) | 7.21700650 |
| 6 | Progressive muscle weakness (HP:0003323) | 6.78074832 |
| 7 | Adactyly (HP:0009776) | 6.68185006 |
| 8 | Hypoplastic pelvis (HP:0008839) | 6.21634895 |
| 9 | Abnormality of fatty-acid metabolism (HP:0004359) | 6.14940930 |
| 10 | Autoamputation (HP:0001218) | 5.86216720 |
| 11 | Dry hair (HP:0011359) | 5.79435982 |
| 12 | Pulmonary artery stenosis (HP:0004415) | 5.60062555 |
| 13 | Ureteral stenosis (HP:0000071) | 5.56050743 |
| 14 | Menstrual irregularities (HP:0000858) | 5.44629556 |
| 15 | Steatorrhea (HP:0002570) | 5.27851364 |
| 16 | Ureteral obstruction (HP:0006000) | 5.14935196 |
| 17 | Ureteral duplication (HP:0000073) | 5.08247324 |
| 18 | Brushfield spots (HP:0001088) | 5.06273262 |
| 19 | Hypoplastic nipples (HP:0002557) | 4.88644495 |
| 20 | Abnormal auditory evoked potentials (HP:0006958) | 4.60530232 |
| 21 | Sudden death (HP:0001699) | 4.45851471 |
| 22 | Abnormal ventriculo-arterial connection (HP:0011563) | 4.35669756 |
| 23 | Transposition of the great arteries (HP:0001669) | 4.35669756 |
| 24 | Abnormal connection of the cardiac segments (HP:0011545) | 4.35669756 |
| 25 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.34325357 |
| 26 | Fat malabsorption (HP:0002630) | 4.09661321 |
| 27 | Increased number of teeth (HP:0011069) | 4.07285722 |
| 28 | Severe muscular hypotonia (HP:0006829) | 4.06564953 |
| 29 | Decreased lacrimation (HP:0000633) | 3.99028125 |
| 30 | Anhidrosis (HP:0000970) | 3.96478094 |
| 31 | Palmoplantar hyperkeratosis (HP:0000972) | 3.81119668 |
| 32 | Broad-based gait (HP:0002136) | 3.68558400 |
| 33 | Palmar hyperkeratosis (HP:0010765) | 3.60767209 |
| 34 | Abnormality of vision evoked potentials (HP:0000649) | 3.44061284 |
| 35 | Polyneuropathy (HP:0001271) | 3.35448678 |
| 36 | Wide intermamillary distance (HP:0006610) | 3.33024589 |
| 37 | Broad nasal tip (HP:0000455) | 3.29532368 |
| 38 | Generalized amyotrophy (HP:0003700) | 3.28309373 |
| 39 | Large hands (HP:0001176) | 3.24162914 |
| 40 | Decreased muscle mass (HP:0003199) | 3.15800375 |
| 41 | Myoglobinuria (HP:0002913) | 3.11544484 |
| 42 | Plantar hyperkeratosis (HP:0007556) | 3.07751536 |
| 43 | Rhabdomyolysis (HP:0003201) | 3.05199040 |
| 44 | Polymicrogyria (HP:0002126) | 2.99359555 |
| 45 | Clubbing of toes (HP:0100760) | 2.72058260 |
| 46 | Flat face (HP:0012368) | 2.65926683 |
| 47 | Steppage gait (HP:0003376) | 2.60302848 |
| 48 | Epiphyseal stippling (HP:0010655) | 2.55296461 |
| 49 | Chorioretinal coloboma (HP:0000567) | 2.52103103 |
| 50 | Hypoplastic iliac wings (HP:0002866) | 2.50792857 |
| 51 | Overfolded helix (HP:0000396) | 2.46397690 |
| 52 | Widely spaced teeth (HP:0000687) | 2.44172806 |
| 53 | Basal ganglia calcification (HP:0002135) | 2.37825280 |
| 54 | Thickened calvaria (HP:0002684) | 2.37240614 |
| 55 | Purpura (HP:0000979) | 2.36349035 |
| 56 | Posterior embryotoxon (HP:0000627) | 2.27707229 |
| 57 | Abnormally folded helix (HP:0008544) | 2.24990755 |
| 58 | Foot dorsiflexor weakness (HP:0009027) | 2.19858354 |
| 59 | Abnormality of the line of Schwalbe (HP:0008048) | 2.19335768 |
| 60 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.15017480 |
| 61 | Anxiety (HP:0000739) | 2.13442273 |
| 62 | Absent toe (HP:0010760) | 2.11219736 |
| 63 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 2.09849407 |
| 64 | Female pseudohermaphroditism (HP:0010458) | 2.07723684 |
| 65 | Hammertoe (HP:0001765) | 2.02640645 |
| 66 | Abnormality of the foot musculature (HP:0001436) | 2.00195313 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 12.1551829 |
| 68 | Prenatal maternal abnormality (HP:0002686) | 1.95724306 |
| 69 | Stereotypic behavior (HP:0000733) | 1.94191913 |
| 70 | External ear malformation (HP:0008572) | 1.93705799 |
| 71 | Thickened nuchal skin fold (HP:0000474) | 1.89115805 |
| 72 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.87392700 |
| 73 | Generalized muscle weakness (HP:0003324) | 1.86546803 |
| 74 | Spastic tetraplegia (HP:0002510) | 1.84969002 |
| 75 | Congenital onset (HP:0003577) | 1.83005714 |
| 76 | Primary adrenal insufficiency (HP:0008207) | 1.82182785 |
| 77 | Gangrene (HP:0100758) | 1.81542552 |
| 78 | Abnormal epiphyseal ossification (HP:0010656) | 1.80172601 |
| 79 | Arthrogryposis multiplex congenita (HP:0002804) | 1.78405328 |
| 80 | Decreased motor nerve conduction velocity (HP:0003431) | 1.78236405 |
| 81 | Arterial thrombosis (HP:0004420) | 1.76229356 |
| 82 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.76093211 |
| 83 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.72221867 |
| 84 | Brachycephaly (HP:0000248) | 1.65542304 |
| 85 | Short philtrum (HP:0000322) | 1.58304696 |
| 86 | Depressed nasal ridge (HP:0000457) | 1.57800418 |
| 87 | Underdeveloped supraorbital ridges (HP:0009891) | 1.55099633 |
| 88 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.54770269 |
| 89 | Nail dystrophy (HP:0008404) | 1.54354752 |
| 90 | Scrotal hypoplasia (HP:0000046) | 1.48221390 |
| 91 | Hypoplastic ilia (HP:0000946) | 1.47700122 |
| 92 | Abnormality of primary teeth (HP:0006481) | 1.38277812 |
| 93 | Opacification of the corneal stroma (HP:0007759) | 1.35238986 |
| 94 | Pulmonary embolism (HP:0002204) | 1.34775131 |
| 95 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.34037812 |
| 96 | Lactic acidosis (HP:0003128) | 1.33117290 |
| 97 | Retinopathy (HP:0000488) | 1.32107418 |
| 98 | Webbed neck (HP:0000465) | 1.28486230 |
| 99 | Freckling (HP:0001480) | 1.27083193 |
| 100 | Postnatal growth retardation (HP:0008897) | 1.25360954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK1 | 6.84182713 |
| 2 | TAOK2 | 5.58014758 |
| 3 | TAOK1 | 5.50981372 |
| 4 | MAP3K3 | 4.14782216 |
| 5 | MAP2K3 | 4.02187312 |
| 6 | MAP3K11 | 3.98587486 |
| 7 | JAK3 | 2.46206964 |
| 8 | MKNK2 | 11.5552025 |
| 9 | ABL2 | 1.87004105 |
| 10 | DYRK1A | 1.75574456 |
| 11 | MAP3K5 | 1.33116808 |
| 12 | MAP3K1 | 1.05811950 |
| 13 | SRPK1 | 0.98680635 |
| 14 | CHEK2 | 0.81457650 |
| 15 | MAP3K8 | 0.68947840 |
| 16 | PRKCQ | 0.47078007 |
| 17 | INSRR | 0.22682288 |
| 18 | PLK4 | 0.19622542 |
| 19 | CSNK1A1 | 0.19280077 |
| 20 | ABL1 | 0.15161979 |
| 21 | MAP4K2 | 0.13141446 |
| 22 | IGF1R | 0.13054753 |
| 23 | OBSCN | 0.09884153 |
| 24 | MUSK | 0.09412358 |
| 25 | PIK3CG | 0.08387789 |
| 26 | MAPK15 | 0.07193803 |
| 27 | PRKCD | 0.06780785 |
| 28 | WNK3 | 0.05280200 |
| 29 | CSNK2A2 | 0.04766714 |
| 30 | TIE1 | 0.04739036 |
| 31 | GRK7 | 0.04680017 |
| 32 | FRK | 0.03764977 |
| 33 | TXK | 0.03127649 |
| 34 | CSNK1E | 0.02170350 |
| 35 | CSNK2A1 | 0.02123468 |
| 36 | PDK2 | 0.01773515 |
| 37 | GRK1 | 0.01493273 |
| 38 | EPHA4 | 0.00806087 |
| 39 | ADRBK2 | 0.00751098 |
| 40 | DDR2 | 0.00482527 |
| 41 | PRKCA | 0.00269831 |
| 42 | RIPK4 | -0.1261224 |
| 43 | UHMK1 | -0.1260533 |
| 44 | CSK | -0.1260026 |
| 45 | EGFR | -0.1254747 |
| 46 | PINK1 | -0.1238256 |
| 47 | PRKACG | -0.1211979 |
| 48 | MAPK7 | -0.1207070 |
| 49 | MOS | -0.1193546 |
| 50 | CDK3 | -0.1176745 |
| 51 | IKBKE | -0.1169152 |
| 52 | MAPK4 | -0.1131239 |
| 53 | PIM1 | -0.1129967 |
| 54 | PRKCE | -0.1110888 |
| 55 | STK39 | -0.1103135 |
| 56 | CDK1 | -0.1100062 |
| 57 | CAMK2G | -0.1094430 |
| 58 | LYN | -0.1086961 |
| 59 | MAP2K6 | -0.1066570 |
| 60 | ADRBK1 | -0.1061612 |
| 61 | BRD4 | -0.1048243 |
| 62 | PRKG1 | -0.1022406 |
| 63 | PIK3CA | -0.1002500 |
| 64 | SYK | -0.1002215 |
| 65 | PRKG2 | -0.0990113 |
| 66 | CAMK2A | -0.0983253 |
| 67 | PIM2 | -0.0982272 |
| 68 | OXSR1 | -0.0979304 |
| 69 | BTK | -0.0956587 |
| 70 | TLK1 | -0.0954924 |
| 71 | PHKG2 | -0.0930638 |
| 72 | PHKG1 | -0.0930638 |
| 73 | WNK4 | -0.0928084 |
| 74 | PRKCG | -0.0917957 |
| 75 | MAPK14 | -0.0916481 |
| 76 | PLK2 | -0.0904422 |
| 77 | PKN1 | -0.0868288 |
| 78 | GRK6 | -0.0861245 |
| 79 | PRKD3 | -0.0857372 |
| 80 | EPHA2 | -0.0837341 |
| 81 | NTRK2 | -0.0818083 |
| 82 | GRK5 | -0.0753441 |
| 83 | CDK2 | -0.0714147 |
| 84 | ITK | -0.0708421 |
| 85 | TNK2 | -0.0707888 |
| 86 | LMTK2 | -0.0637172 |
| 87 | STK38L | -0.0631826 |
| 88 | TEC | -0.0546004 |
| 89 | KDR | -0.0542349 |
| 90 | KIT | -0.0516684 |
| 91 | TTN | -0.0494938 |
| 92 | MATK | -0.0483331 |
| 93 | NEK6 | -0.0376874 |
| 94 | SRC | -0.0305143 |
| 95 | PRKACA | -0.0271362 |
| 96 | MST1R | -0.0270194 |
| 97 | BLK | -0.0246977 |
| 98 | PRKCB | -0.0104679 |
| 99 | ERBB4 | -0.0086610 |
| 100 | AURKA | -0.0031412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 8.60842750 |
| 2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 7.25639939 |
| 3 | Taste transduction_Homo sapiens_hsa04742 | 3.18627690 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.08389566 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.05912168 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.96326822 |
| 7 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.77461518 |
| 8 | Lysine degradation_Homo sapiens_hsa00310 | 2.70950538 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.65933322 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51681277 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.02374611 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.90747964 |
| 13 | Amoebiasis_Homo sapiens_hsa05146 | 1.90329004 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.74518237 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59650368 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47679056 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.36572419 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21095524 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19753525 |
| 20 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.18846701 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15121141 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00547727 |
| 23 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.95067948 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93495246 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84356741 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84117150 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 0.77301738 |
| 28 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71594156 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69322706 |
| 30 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68711032 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68570949 |
| 32 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68254920 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66870799 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65147954 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.64731432 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61044939 |
| 37 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58096808 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54721659 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54035645 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51930970 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50919964 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.50438183 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.48950595 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47100667 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46478614 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44978935 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44936211 |
| 48 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44294465 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43796812 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43524399 |
| 51 | Asthma_Homo sapiens_hsa05310 | 0.42926564 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42060993 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41577535 |
| 54 | Allograft rejection_Homo sapiens_hsa05330 | 0.39121706 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37767517 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37390585 |
| 57 | RNA transport_Homo sapiens_hsa03013 | 0.36195590 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36105482 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35868117 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33282550 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.32855449 |
| 62 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.32165275 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31859157 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30029290 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29374528 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.28643659 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.27596860 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27251118 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25997370 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25672460 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 0.25307629 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24305557 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.23846236 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23508759 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23386323 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.22940541 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.22591384 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22499594 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.21744874 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20646299 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19173296 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16810384 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.15804432 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15462033 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14926125 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.13844316 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.13593472 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13189249 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.12667212 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.12655378 |
| 91 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.11301209 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.10396391 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10322395 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09843309 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.09830112 |
| 96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.09521205 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.08315908 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.06927186 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.06833422 |
| 100 | Salivary secretion_Homo sapiens_hsa04970 | 0.06247279 |

